The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Renal cell carcinoma
Abstract
PURPOSE OF REVIEW: In this review we will highlight the recent novel contributions to the treatment of renal cell carcinoma in the fields of anti-angiogenesis, immunotherapeutics, and surgical management. In addition, this review will update recent advances in diagnostic and imaging modalities for renal cell carcinoma and dietary and environmental relationships to the epidemiology of this growing disease. RECENT FINDINGS: Advancements in the use of innovative treatment strategies for the management of localized renal cell carcinoma and the introduction of new targeted therapeutics with benefit in the metastatic setting has produced a major impact on the treatment of this disease. SUMMARY: The management of metastatic renal cell carcinoma has undergone a revolution in the past year with groundbreaking treatment strategies encompassing a broad range of therapeutic modalities. At the other end of the spectrum, emerging data is beginning to change our perspective about the management of small, localized renal tumors that are being discovered with increasing frequency. This review will update recent findings supporting diet and tobacco exposure as etiologic factors in the development of renal cell carcinoma, the molecular concepts that underlie the disease and the targeted therapeutics designed to inhibit specific kinase activities, and emerging use of minimally invasive therapies for localized disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Motzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61039-9 · Cited by 3,019
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
Prognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Sternberg, C. N., Davis, I. D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C. H., Salman, P., Gladkov, O. A., Kavina, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9764 · Cited by 2,471
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1998) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.1.6 · Cited by 2,341
Escudier, B., Pluzanska, A., Koralewski, P., Ravaud, A., Bracarda, S., Szczylik, C., Chevreau, C., Filipek, M., Melichar, B., Bajetta, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61904-7 · Cited by 2,217
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 2,157
Heng, D. Y. C., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., Eigl, B. J., Ruether, J. D., Cheng, T., North, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4809 · Cited by 2,133
Self-citationEstimates of the worldwide incidence of 25 major cancers in 1990
Parkin, Pisani, P., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p · Cited by 2,037
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
Guideline for Management of the Clinical T1 Renal Mass
Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveillee, R. J., Matin, S. F., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.004 · Cited by 1,831
Self-citationSakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
Motzer, R. J., Mazumdar, M., Bacik, J., Berg, W., Amsterdam, A., & Ferrara, J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2530 · Cited by 1,801
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Flanigan, R. C., Salmon, S. E., Blumenstein, B. A., Bearman, S. I., Roy, V., McGrath, P. C., Caton, J. R., Munshi, N., & Crawford, E. D. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003013 · Cited by 1,715
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,634
Self-citationRini, B. I., Campbell, S. C., & Escudier, B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60229-4 · Cited by 1,621
Self-citationHuang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V., Scardino, P. T., & Russo, P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70803-8 · Cited by 1,613
Rising Incidence of Renal Cell Cancer in the United States
Chow, W.-H. (1999) · JAMA · doi:10.1001/jama.281.17.1628 · Cited by 1,586
Motzer, R. J., Bacik, J., Murphy, B. A., Russo, P., & Mazumdar, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.289 · Cited by 1,576
Estimates of the worldwide mortality from 25 cancers in 1990
Pisani, P., Parkin, D. M., Bray, F., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<18::aid-ijc5>3.0.co;2-m · Cited by 1,549
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Mickisch, G., Garin, A., van Poppel, H., de Prijck, L., & Sylvester, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06103-7 · Cited by 1,410
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
Ljungberg, B., Cowan, N. C., Hanbury, D. C., Hora, M., Kuczyk, M. A., Merseburger, A. S., Patard, J.-J., Mulders, P. F. A., & Sinescu, I. C. (2010) · European Urology · doi:10.1016/j.eururo.2010.06.032 · Cited by 1,263
Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., Redman, B. G., Margolin, K. A., Merchan, J. R., Wilding, G., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2516 · Cited by 1,230
Self-citationFong, T. A. T., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T., Kim, Y. H., Schreck, R., Wang, X., Risau, W., et al. (1999) · PubMed · Cited by 1,109
Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma
Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L., & Blute, M. L. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00005 · Cited by 1,087
Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., & Nakayama, E. (1999) · PubMed · Cited by 1,062
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Poppel, H. V., Pozzo, L. D., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., Maréchal, J.-M., Klotz, L. H., Skinner, E. C., Keane, T. E., et al. (2006) · European Urology · doi:10.1016/j.eururo.2006.11.013 · Cited by 1,040
Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E. J., Tisdale, J., Dunbar, C., Linehan, W. M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009143431101 · Cited by 998
Dannull, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25947 · Cited by 989
Negrier, S., Escudier, B., Lasset, C., Douillard, J.-Y., Savary, J., Chevreau, C., Ravaud, A., Mercatello, A., Peny, J., Mousseau, M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381805 · Cited by 967
Atkins, M. B., Hidalgo, M., Stadler, W. M., Logan, T. F., Dutcher, J. P., Hudes, G. R., Park, Y., Liou, S.-H., Marshall, B., Boni, J. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.185 · Cited by 942
Rini, B. I., Halabi, S., Rosenberg, J. E., Stadler, W. M., Vaena, D. A., Ou, S.-S., Archer, L., Atkins, J. N., Picus, J., Czaykowski, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9847 · Cited by 899
Self-citationCytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis
FLANIGAN, R. C., MICKISCH, G., SYLVESTER, R., TANGEN, C., VAN POPPEL, H., & CRAWFORD, E. D. (2004) · Journal of Urology · doi:10.1097/01.ju.0000110610.61545.ae · Cited by 872
Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Frank, I., Kwon, E. D., Weaver, A. L., Parker, A. S., & Zincke, H. (2003) · Cancer · doi:10.1002/cncr.11234 · Cited by 837
McDermott, D. F., Regan, M. M., Clark, J. I., Flaherty, L. E., Weiss, G. R., Logan, T. F., Kirkwood, J. M., Gordon, M. S., Sosman, J. A., Ernstoff, M. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.206 · Cited by 820
Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer
Yang, J. C., Sherry, R. M., Steinberg, S. M., Topalian, S. L., Schwartzentruber, D. J., Hwu, P., Seipp, C. A., Rogers-Freezer, L., Morton, K. E., White, D. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.122 · Cited by 790
Lau, W. K. O., Blute, M. L., Weaver, A. L., Torres, V. E., & Zincke, H. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.12.1236 · Cited by 755
A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA
KATTAN, M. W., REUTER, V., MOTZER, R. J., KATZ, J., & RUSSO, P. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66077-6 · Cited by 754
Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
Patard, J.-J., Leray, E., Rioux-Leclercq, N., Cindolo, L., Ficarra, V., Zisman, A., De La Taille, A., Tostain, J., Artibani, W., Abbou, C. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.055 · Cited by 754
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Zisman, A., Pantuck, A. J., Dorey, F., Said, J. W., Shvarts, O., Quintana, D., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1649 · Cited by 729
Zisman, A., Pantuck, A. J., Wieder, J., Chao, D. H., Dorey, F., Said, J. W., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.111 · Cited by 675
Obesity, Hypertension, and the Risk of Kidney Cancer in Men
Chow, W.-H., Gridley, G., Fraumeni, J. F., & Järvholm, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431804 · Cited by 668
BUI, M. H. T., Seligson, D. B., Han, K. R., Pantuck, A. J., Dorey, F. J., Huang, Y., Horvath, S., Leibovich, B. C., Chopra, S., Liao, S. Y., et al. (2003) · PubMed · Cited by 654
Ormandy, L. A., Hillemann, T., Wedemeyer, H., Manns, M. P., Greten, T. F., & Korangy, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3232 · Cited by 642
Toro, J. R., Nickerson, M. L., Wei, M.-H., Warren, M. B., Glenn, G. M., Turner, M. L., Stewart, L., Duray, P., Tourre, O., Sharma, N., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376435 · Cited by 634
LAPAROSCOPIC VERSUS OPEN RADICAL NEPHRECTOMY: A 9-YEAR EXPERIENCE
Dunn, M. D., Portis, A. J., Shalhav, A. L., Elbahnasy, A. M., Heidorn, C., McDougall, E. M., & Clayman, R. V. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67131-5 · Cited by 612
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611
Renal cell cancer stage migration: Analysis of the National Cancer Data Base
Kane, C. J., Mallin, K., Ritchey, J., Cooperberg, M. R., & Carroll, P. R. (2008) · Cancer · doi:10.1002/cncr.23518 · Cited by 604
(1999) · The Lancet · doi:10.1016/s0140-6736(98)03544-2 · Cited by 601
LEIBOVICH, B. C., BLUTE, M. L., CHEVILLE, J. C., LOHSE, C. M., WEAVER, A. L., & ZINCKE, H. (2004) · Journal of Urology · doi:10.1097/01.ju.0000113274.40885.db · Cited by 581
Resection of metastatic renal cell carcinoma.
Kavolius, J. P., Mastorakos, D. P., Pavlovich, C., Russo, P., Burt, M. E., & Brady, M. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2261 · Cited by 559
Mekhail, T. M., Abou-Jawde, R. M., BouMerhi, G., Malhi, S., Wood, L., Elson, P., & Bukowski, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.179 · Cited by 559
Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram
Karakiewicz, P. I., Briganti, A., Chun, F. K.-H., Trinh, Q.-D., Perrotte, P., Ficarra, V., Cindolo, L., De La Taille, A., Tostain, J., Mulders, P. F. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1218 · Cited by 536
Natural history of chronic renal insufficiency after partial and radical nephrectomy
McKiernan, J., Simmons, R., Katz, J., & Russo, P. (2002) · Urology · doi:10.1016/s0090-4295(02)01501-7 · Cited by 533
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528
SORBELLINI, M., KATTAN, M. W., SNYDER, M. E., REUTER, V., MOTZER, R., GOETZL, M., McKIERNAN, J., & RUSSO, P. (2005) · Journal of Urology · doi:10.1097/01.ju.0000148261.19532.2c · Cited by 528
The natural history of incidentally detected small renal masses
Volpe, A., Panzarella, T., Rendon, R. A., Haider, M. A., Kondylis, F. I., & Jewett, M. A. S. (2004) · Cancer · doi:10.1002/cncr.20025 · Cited by 526
Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies
Hunt, J. D., van der Hel, O. L., McMillan, G. P., Boffetta, P., & Brennan, P. (2005) · International Journal of Cancer · doi:10.1002/ijc.20618 · Cited by 525
Sun, L., Liang, C., Shirazian, S., Zhou, Y., Miller, T., Cui, J., Fukuda, J. Y., Chu, J.-Y., Nematalla, A., Wang, X., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0204183 · Cited by 521
Excise, Ablate or Observe: The Small Renal Mass Dilemma—A Meta-Analysis and Review
Kunkle, D. A., Egleston, B. L., & Uzzo, R. G. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.11.047 · Cited by 517
Bjorge, T., Tretli, S., & Engeland, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh345 · Cited by 492
Cairns, P. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0176 · Cited by 485
Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., & Zbar, B. (1994) · PubMed · Cited by 471
The Genetic Basis of Cancer of the Kidney
LINEHAN, W. M., WALTHER, M. M., & ZBAR, B. (2003) · Journal of Urology · doi:10.1097/01.ju.0000096060.92397.ed · Cited by 470
Proline hydroxylation and gene expression
Kaelin, W. G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133142 · Cited by 468
Luciani, L. G., Cestari, R., & Tallarigo, C. (2000) · Urology · doi:10.1016/s0090-4295(00)00534-3 · Cited by 452
An update of the Bosniak renal cyst classification system
Israel, G. M., & Bosniak, M. A. (2005) · Urology · doi:10.1016/j.urology.2005.04.003 · Cited by 444
Pyrhönen, S., Salminen, E., Ruutu, M., Lehtonen, T., Nurmi, M., Tammela, T., Juusela, H., Rintala, E., Hietanen, P., & Kellokumpu-Lehtinen, P.-L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2859 · Cited by 441
Jocham, D., Richter, A., Hoffmann, L., Iwig, K., Fahlenkamp, D., Zakrzewski, G., Schmitt, E., Dannenberg, T., Lehmacher, W., von Wietersheim, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15590-6 · Cited by 434
Akt-dependent transformation: there is more to growth than just surviving
Plas, D. R., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209097 · Cited by 429
The Epidemiology of Renal Cell Carcinoma
Lipworth, L., Tarone, R. E., & McLaughlin, J. K. (2006) · Journal of Urology · doi:10.1016/j.juro.2006.07.130 · Cited by 424
Patard, J.-J., Kim, H. L., Lam, J. S., Dorey, F. J., Pantuck, A. J., Zisman, A., Ficarra, V., Han, K.-R., Cindolo, L., De La Taille, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.104 · Cited by 423
HOCK, L. M., LYNCH, J., & BALAJI, K. C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65382-7 · Cited by 420
Discovery of a novel Raf kinase inhibitor.
Lyons, J. F., Wilhelm, S., Hibner, B., & Bollag, G. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080219 · Cited by 416
Simons, J. W., Jaffee, E. M., Weber, C. E., Levitsky, H. J., Nelson, W. G., Carducci, M. A., Lazenby, A. J., Cohen, L. K., Finn, C. C., Clift, S. M., et al. (1998) · The Journal of Urology · doi:10.1097/00005392-199802001-00032 · Cited by 410
Takahashi, M., Rhodes, D. R., Furge, K. A., Kanayama, H.-O., Kagawa, S., Haab, B. B., & Teh, B. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171209998 · Cited by 403
Rini, B. I., Michaelson, M. D., Rosenberg, J. E., Bukowski, R. M., Sosman, J. A., Stadler, W. M., Hutson, T. E., Margolin, K., Harmon, C. S., DePrimo, S. E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5416 · Cited by 393
Self-citationMoch, H., Schraml, P., Bubendorf, L., Mirlacher, M., Kononen, J., Gasser, T., Mihatsch, M. J., Kallioniemi, O. P., & Sauter, G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65349-7 · Cited by 391
Kourembanas, S., Hannan, R. L., & Faller, D. V. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114759 · Cited by 386
Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Rini, B. I., Tamaskar, I., Shaheen, P., Salas, R., Garcia, J., Wood, L., Reddy, S., Dreicer, R., & Bukowski, R. M. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk008 · Cited by 378
Self-citationSu, Z. Z., Dannull, J., Heiser, A., Yancey, D. R., Pruitt, S. K., Madden, J., Coleman, D., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2003) · PubMed · Cited by 366
Wiesener, M. S., Münchenhagen, P., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jürgensen, J. S., Gruber, G., Maxwell, P. H., Löning, S. A., et al. (2001) · PubMed · Cited by 354
Siemes, C., Visser, L. E., Coebergh, J.-W. W., Splinter, T. A. W., Witteman, J. C. M., Uitterlinden, A. G., Hofman, A., Pols, H. A. P., & Stricker, B. H. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1381 · Cited by 354
Carroll, V. A., & Ashcroft, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2519 · Cited by 352
高橋, 敦. (1994) · Medical Entomology and Zoology · doi:10.11501/3101325 · Cited by 352
STAGE SPECIFIC GUIDELINES FOR SURVEILLANCE AFTER RADICAL NEPHRECTOMY FOR LOCAL RENAL CELL CARCINOMA
LEVY, D. A., SLATON, J. W., SWANSON, D. A., & DINNEY, C. P. N. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63541-9 · Cited by 351
Escudier, B., Szczylik, C., Eisen, T., Stadler, W. M., Schwartz, B., Shan, M., & Bukowski, R. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba4510 · Cited by 348
Waldmann, T. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49895-x · Cited by 345
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
Hergovich, A., Lisztwan, J., Barry, R., Ballschmieter, P., & Krek, W. (2003) · Nature Cell Biology · doi:10.1038/ncb899 · Cited by 339
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
Kaelin, W. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1865 · Cited by 336
Shaheen, R. M., Davis, D. W., Liu, W., Zebrowski, B. K., Wilson, M. R., Bucana, C. D., McConkey, D. J., McMahon, G., & Ellis, L. M. (1999) · PubMed · Cited by 334
Nephron Sparing Surgery for Renal Cell Carcinoma
Licht, M. R., & Novick, A. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35982-7 · Cited by 330
Cytogenetics of papillary renal cell tumors
Kovacs, G., Fuzesi, L., Emanuel, A., & Kung, H. (1991) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870030403 · Cited by 320
Bukowski, R. M., Kabbinavar, F. F., Figlin, R. A., Flaherty, K., Srinivas, S., Vaishampayan, U., Drabkin, H. A., Dutcher, J., Ryba, S., Xia, Q., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5154 · Cited by 315
Obesity and renal cell cancer – a quantitative review
Bergström, A., Hsieh, C.-C., Lindblad, P., Lu, C.-M., Cook, N. R., & Wolk, A. (2001) · British Journal of Cancer · doi:10.1038/sj.bjc.6692040 · Cited by 314
Messing, E. M., Manola, J. B., Wilding, G., PROPERT, K. J., Fleischmann, J. D., Crawford, E. D., Pontes, J. E., Hahn, R. G., & Trump, D. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.005 · Cited by 309
Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell Carcinoma
Gleave, M. E., Elhilali, M., Fradet, Y., Davis, I., Venner, P., Saad, F., Klotz, L. H., Moore, M. J., Paton, V., Bajamonde, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381804 · Cited by 308
NEUZILLET, Y., LECHEVALLIER, E., ANDRE, M., DANIEL, L., & COULANGE, C. (2004) · Journal of Urology · doi:10.1097/01.ju.0000120147.51090.2b · Cited by 308
PERCUTANEOUS RADIO FREQUENCY ABLATION OF SMALL RENAL TUMORS: INITIAL RESULTS
PAVLOVICH, C. P., WALTHER, M. M., CHOYKE, P. L., PAUTLER, S. E., CHANG, R., LINEHAN, W. M., & WOOD, B. J. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65371-2 · Cited by 308
Turner, K., Moore, J. W., Jones, A., Taylor, C., Cuthbert-Heavens, D., Cheng, H., Leek, R., Gatter, K. C., Maxwell, P. H., Ratcliffe, P. J., et al. (2002) · PubMed · Cited by 303
Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
Donskov, F., & von der Maase, H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9594 · Cited by 299
Association of CKD and Cancer Risk in Older People
Wong, G., Hayen, A., Chapman, J. R., Webster, A. C., Wang, J. J., Mitchell, P., & Craig, J. C. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008090998 · Cited by 293
Pesch, B., Haerting, J., Ranft, U., Klimpel, A., Oelschlägel, B., & Schill, W. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.6.1014 · Cited by 292
Wilhelm, S., & Chien, D.-S. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023393026 · Cited by 289
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Semenza, G. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9081-2 · Cited by 281
Banks, R. E., Tirukonda, P., Taylor, C., Hornigold, N., Astuti, D., Cohen, D., Maher, E. R., Stanley, A. J., Harnden, P., Joyce, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3074 · Cited by 275
Clifford, S. C., Prowse, A. H., Affara, N. A., Buys, C. H. C. M., & Maher, E. R. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-# · Cited by 270
RENAL CELL CARCINOMA: MANAGEMENT OF ADVANCED DISEASE
FIGLIN, R. A. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61897-4 · Cited by 266
Motzer, R. J., Murphy, B. A., Bacik, J., Schwartz, L. H., Nanus, D. M., Mariani, T., Loehrer, P., Wilding, G., Fairclough, D. L., Cella, D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2972 · Cited by 264
Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA Microarray
Higgins, J. P. T., Shinghal, R., Gill, H., Reese, J. H., Terris, M., Cohen, R. J., Fero, M., Pollack, J. R., van de Rijn, M., & Brooks, J. D. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63887-4 · Cited by 260
Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J. (2005) · Neoplasia · doi:10.1593/neo.04430 · Cited by 251
Yao, M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1569 · Cited by 249
Unwin, R. D., Craven, R. A., Harnden, P., Hanrahan, S., Totty, N., Knowles, M., Eardley, I., Selby, P. J., & Banks, R. E. (2003) · PROTEOMICS · doi:10.1002/pmic.200300464 · Cited by 247
Choyke, P. L., Glenn, G. M., Walther, M. M., Zbar, B., & Linehan, W. M. (2003) · Radiology · doi:10.1148/radiol.2261011296 · Cited by 246
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors
Zimmer, M., Doucette, D., Siddiqui, N., & Iliopoulos, O. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.89.2.2 · Cited by 244
pVHL and GSK3β are components of a primary cilium-maintenance signalling network
Thoma, C. R., Frew, I. J., Hoerner, C. R., Montani, M., Moch, H., & Krek, W. (2007) · Nature Cell Biology · doi:10.1038/ncb1579 · Cited by 238
Using Protein Expressions to Predict Survival in Clear Cell Renal Carcinoma
Kim, H. L., Seligson, D., Liu, X., Janzen, N., Bui, M. H. T., Yu, H., Shi, T., Figlin, R. A., Horvath, S., & Belldegrun, A. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0488 · Cited by 233
Pischon, T., Lahmann, P. H., Boeing, H., Tjønneland, A., Halkjær, J., Overvad, K., Klipstein‐Grobusch, K., Linseisen, J., Becker, N., Trichopoulou, A., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21398 · Cited by 229
Choueiri, T. K., Garcia, J. A., Elson, P., Khasawneh, M., Usman, S., Golshayan, A. R., Baz, R. C., Wood, L., Rini, B. I., & Bukowski, R. M. (2007) · Cancer · doi:10.1002/cncr.22827 · Cited by 228
Self-citationLipton, A., Zheng, M., & Seaman, J. (2003) · Cancer · doi:10.1002/cncr.11571 · Cited by 223
Atzpodien, J., Kirchner, H., Jonas, U., Bergmann, L., Schott, H., Heynemann, H., Fornara, P., Loening, S. A., Roigas, J., Müller, S. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.155 · Cited by 223
Weikert, S., Boeing, H., Pischon, T., Weikert, C., Olsen, A., Tjonneland, A., Overvad, K., Becker, N., Linseisen, J., Trichopoulou, A., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm321 · Cited by 218
USING TUMOR MARKERS TO PREDICT THE SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
KIM, H. L., SELIGSON, D., LIU, X., JANZEN, N., BUI, M. H. T., YU, H., SHI, T., BELLDEGRUN, A. S., HORVATH, S., & FIGLIN, R. A. (2005) · Journal of Urology · doi:10.1097/01.ju.0000154351.37249.f0 · Cited by 216
Figlin, R. A., Thompson, J. A., Bukowski, R. M., Vogelzang, N. J., Novick, A. C., Lange, P., Steinberg, G. D., & Belldegrun, A. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2521 · Cited by 212
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
Motzer, R. J., Bukowski, R. M., Figlin, R. A., Hutson, T. E., Michaelson, M. D., Kim, S. T., Baum, C. M., & Kattan, M. W. (2008) · Cancer · doi:10.1002/cncr.23776 · Cited by 211
Is there an association between hypertension and cancer mortality?
Grossman, E., Messerli, F. H., Boyko, V., & Goldbourt, U. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01049-5 · Cited by 209
Stadler, W. M., Vogelzang, N. J., Amato, R., Sosman, J., Taber, D., Liebowitz, D., & Vokes, E. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.371 · Cited by 208
CYTOTOXIC CHEMOTHERAPY FOR ADVANCED RENAL CELL CARCINOMA
Yagoda, A., Petrylak, D., & Thompson, S. (1993) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00489-4 · Cited by 207
Leibovich, B. C., Sheinin, Y., Lohse, C. M., Thompson, R. H., Cheville, J. C., Zavada, J., & Kwon, E. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1087 · Cited by 196
Igarashi, T., Wynberg, J., Srinivasan, R., Becknell, B., McCoy, J. P., Takahashi, Y., Suffredini, D. A., Linehan, W. M., Caligiuri, M. A., & Childs, R. W. (2004) · Blood · doi:10.1182/blood-2003-12-4438 · Cited by 195
NA, X. I., WU, G., RYAN, C. K., SCHOEN, S. R., di’SANTAGNESE, P. A., & MESSING, E. M. (2003) · Journal of Urology · doi:10.1097/01.ju.0000074870.54671.98 · Cited by 194
Gunaratnam, L., Morley, M., Franovic, A., de Paulsen, N., Mekhail, K., Parolin, D. A. E., Nakamura, E., Lorimer, I. A. J., & Lee, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305502200 · Cited by 188
Weight, C. J., Lieser, G., Larson, B. T., Gao, T., Lane, B. R., Campbell, S. C., Gill, I. S., Novick, A. C., & Fergany, A. F. (2010) · European Urology · doi:10.1016/j.eururo.2010.04.033 · Cited by 188
Self-citationde Paulsen, N., Brychzy, A., Fournier, M.-C., Klausner, R. D., Gnarra, J. R., Pause, A., & Lee, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1387 · Cited by 187
Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic.
Huang, S., & Houghton, P. J. (2002) · PubMed · Cited by 186
Strict regulation of CAIXG250/MN by HIF-1α in clear cell renal cell carcinoma
Grabmaier, K., de Weijert, M. C., Verhaegh, G. W., Schalken, J. A., & Oosterwijk, E. (2004) · Oncogene · doi:10.1038/sj.onc.1207764 · Cited by 186
Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer.
Wilhelm, M., Veltman, J. A., Olshen, A. B., Jain, A. N., Moore, D. H., Presti, J. C., Kovács, G., & Waldman, F. M. (2002) · PubMed · Cited by 183
NEUMANN, H. P. H., BENDER, B. U., BERGER, D. P., LAUBENBERGER, J., SCHULTZE-SEEMANN, W., WETTERAUER, U., FERSTL, F. J., HERBST, E. W., SCHWARZKOPF, G., HES, F. J., et al. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62509-6 · Cited by 183
Pantuck, A. J., Zeng, G., Belldegrun, A. S., & Figlin, R. A. (2003) · PubMed · Cited by 182
KATO, M., SUZUKI, T., SUZUKI, Y., TERASAWA, Y., SASANO, H., & ARAI, Y. (2004) · Journal of Urology · doi:10.1097/01.ju.0000136315.80057.99 · Cited by 175
Vasselli, J. R., Shih, J. H., Iyengar, S. R., Maranchie, J., Riss, J., Worrell, R., Torres-Cabala, C., Tabios, R., Mariotti, A., Stearman, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131754100 · Cited by 175
Body Size and Renal Cell Cancer Incidence in a Large US Cohort Study
Adams, K. F., Leitzmann, M. F., Albanes, D., Kipnis, V., Moore, S. C., Schatzkin, A., & Chow, W.-H. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn122 · Cited by 174
Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
Knebelmann, B., Karumanchi, S. A., Cohen, H. T., & Sukhatme, V. P. (1998) · PubMed · Cited by 170
TSUI, K.-H., SHVARTS, O., BARBARIC, Z., FIGLIN, R., de KERNION, J. B., & BELLDEGRUN, A. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67895-0 · Cited by 168
Figlin, R. A., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Négrier, S., Huang, X., Kim, S. T., Chen, I., & Motzer, R. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.5024 · Cited by 168
HISTOPATHOLOGY AND MOLECULAR GENETICS OF RENAL TUMORS: TOWARD UNIFICATION OF A CLASSIFICATION SYSTEM
ZAMBRANO, N. R., LUBENSKY, I. A., MERINO, M. J., LINEHAN, W. M., & WALTHER, M. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68259-6 · Cited by 167
VASSELLI, J. R., YANG, J. C., LINEHAN, W. M., WHITE, D. E., ROSENBERG, S. A., & WALTHER, M. M. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66078-8 · Cited by 165
The von Hippel–Lindau Protein, Vascular Endothelial Growth Factor, and Kidney Cancer
George, D. J., & Kaelin, W. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030061 · Cited by 165
Figlin, R. A., Pierce, W. C., Kaboo, R., Tso, C. L., Moldawer, N., Gitlitz, B., deKernion, J., & Belldegrun, A. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64304-0 · Cited by 160
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
Brugarolas, J., & Kaelin, W. G. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.020 · Cited by 160
Overexpression of KIT in chromophobe renal cell carcinoma
Yamazaki, K., Sakamoto, M., Ohta, T., Kanai, Y., Ohki, M., & Hirohashi, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206153 · Cited by 160
Motzer, R. J., Amato, R. J., Todd, M. B., Poo, W.-J., Cohen, R. B., Baselga, J. M., Muss, H. B., Cooper, M. R., Yu, R., Ginsberg, M. S., et al. (2003) · Investigational New Drugs · doi:10.1023/a:1022928612511 · Cited by 154
Cancer and Leukemia Group B 90206
Rini, B. I., Halabi, S., Taylor, J., Small, E. J., Schilsky, R. L., & for the Cancer Leukemia Group B (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0605 · Cited by 153
Self-citationRyan, C. W., Goldman, B. H., Lara, P. N., Mack, P. C., Beer, T. M., Tangen, C. M., Lemmon, D., Pan, C.-X., Drabkin, H. A., & Crawford, E. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1047 · Cited by 151
Zisman, A., Pantuck, A. J., Chao, D. H., DOREY, F. J., SAID, J. W., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66075-2 · Cited by 151
Vascular endothelial growth factor expression is increased in renal cell carcinoma.
Nicol, D. L., Hii, S.-I., Walsh, M. D., Teh, B. T., Thompson, L. C., Kennett, C., & Gotley, D. C. (1997) · PubMed · Cited by 150
Hypertension, obesity and their medications in relation to renal cell carcinoma
Yuan, J.-M., Castelao, J. E., Gago-Domínguez, M., Ross, R. K., & Yu, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.248 · Cited by 148
Gollob, J., Veenstra, K. G., Parker, R. A., Mier, J. W., McDermott, D. F., Clancy, D., Tutin, L., Koon, H. B., & Atkins, M. B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.119 · Cited by 148
Zatyka, M., da Silva, N. F., Clifford, S. C., Morris, M. R., Wiesener, M. S., Eckardt, K., Houlston, R. S., Richards, F. M., Latif, F., & Maher, E. R. (2002) · PubMed · doi:10.25405/ncl.34582002 · Cited by 147
Tomisawa, M., Tokunaga, T., Oshika, Y., Tsuchida, T., Fukushima, Y., Sato, H., Kijima, H., Yamazaki, H., Ueyama, Y., Tamaoki, N., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00278-0 · Cited by 147
Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer
Atzpodien, J., Kirchner, H. H., Hänninen, E. L., Deckert, P. M., Fenner, M. H., & POLIWODA, H. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90617-o · Cited by 143
Tamaskar, I., Garcia, J. A., Elson, P. J., Wood, L. S., Mekhail, T. M., Dreicer, R., Rini, B. I., & Bukowski, R. M. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.08.127 · Cited by 143
Self-citationThe von Hippel-Lindau gene, kidney cancer, and oxygen sensing.
Kaelin, W. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092803.69761.41 · Cited by 135
Négrier, S., Caty, A., Lesimple, T., Douillard, J., Escudier, B. J., Rossi, J., Viens, P., & Gomez, F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4009 · Cited by 135
Phase II Trial of Thalidomide for Patients With Advanced Renal Cell Carcinoma
Motzer, R. J., Berg, W. J., Ginsberg, M. S., Russo, P., Vuky, J., Yu, R., Bacik, J., & Mazumdar, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.302 · Cited by 133
Rioux-Leclercq, N. C., Turlin, B., Bansard, J., Patard, J., Manunta, A. F., Moulinoux, J.-P., Guillé, F., Ramée, M. P., & Lobel, B. (2000) · Urology · doi:10.1016/s0090-4295(99)00550-6 · Cited by 129
Bevacizumab for Patients with Metastatic Renal Cancer
Yang, J. C.-H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-050006 · Cited by 128
Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
Mukherji, B., Guha, A. A., Chakraborty, N. G., Sivanandham, M., Nashed, A. L., Sporn, J., & Ergin, M. T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.6.1961 · Cited by 128
Dendritic cell?tumor cell hybrid vaccination for metastatic cancer
Barbuto, J. A. M., Ensina, L. F., Neves, A., Bergami-Santos, P. C., Leite, K. R. M., Marques, R. J., Costa, F. P., Martins, S. C., Camara-Lopes, L. H. A., & Buzaid, A. C. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0551-7 · Cited by 128
Kuenen, B. C., Tabernero, J. M., Baselga, J., et al. (2003) · PubMed · Cited by 127
Alcohol Intake and Renal Cell Cancer in a Pooled Analysis of 12 Prospective Studies
Lee, J. E., Hunter, D. J., Spiegelman, D., Adami, H.-O., Albanes, D., Bernstein, L., van den Brandt, P. A., Buring, J. E., Cho, E., Folsom, A. R., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk181 · Cited by 126
Jones, T. D., Eble, J. N., Wang, M., MacLennan, G. T., Jain, S. K., & Liang Cheng, C. (2005) · Cancer · doi:10.1002/cncr.21288 · Cited by 125
Expression of vascular endothelial growth factor in renal cell carcinomas
Paradis, V., Lagha, N. B., ZEIMOURA, L., Blanchet, P., Eschwège, P., Ba, N., Benoît, G., Jardin, A., & Bédossa, P. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050458 · Cited by 125
Miyata, Y., Koga, S., Kanda, S., Nishikido, M., Hayashi, T., & Kanetake, H. (2003) · PubMed · Cited by 124
Rini, B. I., Jaeger, E., Weinberg, V. E., Sein, N., Chew, K., Fong, K., Simko, J., Small, E. J., & Waldman, F. M. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06376.x · Cited by 119
Self-citationCruciferous vegetables in relation to renal cell carcinoma
Yuan, J., Gago-Domínguez, M., Castelao, J. E., Hankin, J. H., Ross, R. K., & Yu, M. C. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980717)77:2<211::aid-ijc7>3.0.co;2-t · Cited by 118
Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
Bukowski, R. M., Ernstoff, M. S., Gore, M. E., Nemunaitis, J. J., Amato, R. J., Gupta, S. K., & Tendler, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.051 · Cited by 117
Mole, D. R., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · IUBMB Life · doi:10.1080/15216540252774757 · Cited by 117
A Clinical View of Simple and Complex Renal Cysts
Eknoyan, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040441 · Cited by 117
Cited by
Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W., & Charbonneau, C. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.12.001 · Cited by 974
Overweight, obesity, and cancer risk
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 929
Chang, Y. S., Adnane, J., Trail, P. A., Levy, J., Henderson, A., Xue, D., Bortolon, E., Ichetovkin, M., Chen, C., McNabola, A., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0393-4 · Cited by 459
Pantuck, A. J., Seligson, D. B., Klatte, T., Yu, H., Leppert, J. T., Moore, L., O'Toole, T., Gibbons, J., Belldegrun, A. S., & Figlin, R. A. (2007) · Cancer · doi:10.1002/cncr.22677 · Cited by 350
Increased cancer risk after liver transplantation: a population-based study
Haagsma, E. B., Hagens, V. E., Schaapveld, M., van den Berg, A. P., de Vries, E. G. E., Klompmaker, I. J., Slooff, M. J. H., & Jansen, P. L. M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00077-5 · Cited by 323
Metadata
- Authors
- Rini, B. I., Campbell, S. C., & Rathmell, W. K.
- Venue
- Current Opinion in Oncology
- Published
- 2006-05
- Volume
- 18
- Issue
- 3
- Pages
- 289-296
- ISSN
- 1040-8746 (ISSN-L)
- OpenAlex
- W2148898638
- Cited by
- 379
- References
- 291
- FWCI
- 22.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.